Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rocket Pharmaceuticals, Inc. (RCKT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rocket Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1281895.
Total stock buying since 2015: $75,949,428.
Total stock sales since 2015: $47,539,773.
Total stock option exercises since 2015: $990,615.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 51,099 | $234,865 | 84,771 | $555,832 | 0 | $0 |
| 2024 | 0 | $0 | 381,806 | $10,492,327 | 118,251 | $125,500 |
| 2023 | 0 | $0 | 67,745 | $1,378,157 | 49,362 | $0 |
| 2022 | 1,377,932 | $20,381,521 | 45,000 | $731,250 | 0 | $0 |
| 2021 | 0 | $0 | 760,085 | $30,666,902 | 394,371 | $590,048 |
| 2020 | 248,720 | $13,881,820 | 16,761 | $952,678 | 380,925 | $164,667 |
| 2019 | 775,005 | $14,631,337 | 74,900 | $1,286,271 | 0 | $0 |
| 2018 | 5,675 | $85,011 | 97,137 | $1,476,356 | 230,869 | $67,601 |
| 2017 | 60,000 | $105,000 | 0 | $0 | 12,500 | $0 |
| 2016 | 10,000 | $90,290 | 0 | $0 | 0 | $0 |
| 2015 | 4,423,264 | $26,539,584 | 0 | $0 | 9,857 | $42,799 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 10,000 | $34,100 | 35,450 | $107,135 | 0 | $0 |
| 2025-07 | 0 | $0 | 1,477 | $4,256 | 0 | $0 |
| 2025-05 | 0 | $0 | 4,765 | $30,713 | 0 | $0 |
| 2025-04 | 41,099 | $200,765 | 8,207 | $44,785 | 0 | $0 |
| 2025-02 | 0 | $0 | 34,872 | $368,943 | 0 | $0 |
| 2024-11 | 0 | $0 | 3,097 | $40,415 | 0 | $0 |
| 2024-10 | 0 | $0 | 3,997 | $66,450 | 0 | $0 |
| 2024-08 | 0 | $0 | 18,440 | $341,201 | 0 | $0 |
| 2024-07 | 0 | $0 | 3,838 | $80,403 | 0 | $0 |
| 2024-05 | 0 | $0 | 13,623 | $318,095 | 17,662 | $0 |
| 2024-04 | 0 | $0 | 13,365 | $327,813 | 0 | $0 |
| 2024-03 | 0 | $0 | 276,490 | $7,860,894 | 0 | $0 |
| 2024-02 | 0 | $0 | 48,318 | $1,439,701 | 99,003 | $125,500 |
| 2024-01 | 0 | $0 | 638 | $17,355 | 1,586 | $0 |
| 2023-11 | 0 | $0 | 20,000 | $450,640 | 12,693 | $0 |
| 2023-10 | 0 | $0 | 564 | $9,622 | 3,333 | $0 |
| 2023-09 | 0 | $0 | 14,989 | $315,743 | 0 | $0 |
| 2023-08 | 0 | $0 | 6,585 | $101,875 | 12,693 | $0 |
| 2023-07 | 0 | $0 | 573 | $10,905 | 1,586 | $0 |
| 2023-05 | 0 | $0 | 5,697 | $121,771 | 12,693 | $0 |
| 2023-04 | 0 | $0 | 2,342 | $43,678 | 6,364 | $0 |
| 2023-02 | 0 | $0 | 16,995 | $323,923 | 0 | $0 |
| 2022-10 | 1,355,932 | $19,999,997 | 0 | $0 | 0 | $0 |
| 2022-03 | 0 | $0 | 45,000 | $731,250 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-27 | Bjork Elisabeth | Buy | 10,000 | 3.41 | 34,100 |
| 2025-08-19 | Schwartz Jonathan David (See Remarks) | Sale | 805 | 3.00 | 2,411 |
| 2025-08-19 | Wilson Martin (General Counsel) | Sale | 588 | 3.00 | 1,761 |
| 2025-08-19 | Militello John (See Remarks) | Sale | 361 | 3.00 | 1,081 |
| 2025-08-18 | Schwartz Jonathan David (See Remarks) | Sale | 1,680 | 3.06 | 5,149 |
| 2025-08-18 | Wilson Martin (General Counsel) | Sale | 1,004 | 3.06 | 3,077 |
| 2025-08-18 | Militello John (See Remarks) | Sale | 699 | 3.06 | 2,142 |
| 2025-08-14 | Schwartz Jonathan David (See Remarks) | Sale | 11,161 | 3.02 | 33,695 |
| 2025-08-14 | Wilson Martin (General Counsel) | Sale | 12,109 | 3.02 | 36,557 |
| 2025-08-14 | Militello John (See Remarks) | Sale | 7,043 | 3.02 | 21,262 |
| 2025-07-03 | Ondrey Aaron (Chief Financial Officer) | Sale | 1,477 | 2.88 | 4,256 |
| 2025-05-20 | Schwartz Jonathan David (See Remarks) | Sale | 801 | 6.45 | 5,163 |
| 2025-05-20 | Patel Kinnari (See Remarks) | Sale | 767 | 6.45 | 4,944 |
| 2025-05-20 | Shah Gaurav (CEO) | Sale | 2,253 | 6.45 | 14,522 |
| 2025-05-20 | Wilson Martin (General Counsel) | Sale | 587 | 6.45 | 3,783 |
| 2025-05-20 | Militello John (See Remarks) | Sale | 357 | 6.45 | 2,301 |
| 2025-04-22 | Militello John (See Remarks) | Sale | 718 | 7.16 | 5,139 |
| 2025-04-10 | Shah Gaurav (CEO) | Buy | 20,000 | 5.08 | 101,600 |
| 2025-04-09 | Patel Kinnari (See Remarks) | Buy | 21,099 | 4.70 | 99,165 |
| 2025-04-04 | Ondrey Aaron (Chief Financial Officer) | Sale | 7,489 | 5.29 | 39,646 |
| 2025-02-25 | Schwartz Jonathan David (See Remarks) | Sale | 6,532 | 10.58 | 69,108 |
| 2025-02-21 | Patel Kinnari (See Remarks) | Sale | 6,078 | 10.58 | 64,305 |
| 2025-02-21 | Shah Gaurav (CEO) | Sale | 16,303 | 10.58 | 172,485 |
| 2025-02-21 | Wilson Martin (General Counsel) | Sale | 3,222 | 10.58 | 34,088 |
| 2025-02-21 | Militello John (See Remarks) | Sale | 2,737 | 10.58 | 28,957 |
| 2024-11-21 | Schwartz Jonathan David (See Remarks) | Sale | 3,097 | 13.05 | 40,415 |
| 2024-10-31 | White Mark Andrew (See Remarks) | Sale | 3,080 | 16.62 | 51,205 |
| 2024-10-31 | Militello John (See Remarks) | Sale | 917 | 16.62 | 15,245 |
| 2024-08-16 | Schwartz Jonathan David (See Remarks) | Sale | 2,710 | 18.50 | 50,135 |
| 2024-08-16 | Patel Kinnari (See Remarks) | Sale | 3,989 | 18.50 | 73,812 |
| 2024-08-16 | Shah Gaurav (CEO) | Sale | 9,650 | 18.50 | 178,563 |
| 2024-08-16 | Wilson Martin (General Counsel) | Sale | 1,027 | 18.50 | 19,003 |
| 2024-08-16 | Militello John (See Remarks) | Sale | 1,064 | 18.50 | 19,688 |
| 2024-07-22 | Militello John (See Remarks) | Sale | 812 | 23.02 | 18,688 |
| 2024-07-08 | White Mark Andrew (See Remarks) | Sale | 3,026 | 20.39 | 61,715 |
| 2024-05-17 | Schwartz Jonathan David (See Remarks) | Sale | 2,754 | 23.35 | 64,305 |
| 2024-05-16 | Shah Gaurav (CEO) | Sale | 9,790 | 23.35 | 228,596 |
| 2024-05-16 | Militello John (See Remarks) | Sale | 1,079 | 23.35 | 25,194 |
| 2024-05-14 | Shah Gaurav (CEO) | Option Ex | 17,662 | .00 | 0 |
| 2024-04-22 | Militello John (See Remarks) | Sale | 833 | 22.87 | 19,050 |
| 2024-04-08 | White Mark Andrew (See Remarks) | Sale | 12,532 | 24.64 | 308,763 |
| 2024-03-21 | Makker Gotham | Sale | 274,000 | 28.43 | 7,790,916 |
| 2024-03-21 | Militello John (See Remarks) | Sale | 2,490 | 28.10 | 69,978 |
| 2024-02-29 | Wilson Martin (General Counsel) | Sale | 4,100 | 29.33 | 120,257 |
| 2024-02-29 | Militello John (See Remarks) | Sale | 10,000 | 29.84 | 298,450 |
| 2024-02-29 | Militello John (See Remarks) | Option Ex | 10,000 | 12.55 | 125,500 |
| 2024-02-16 | Patel Kinnari (See Remarks) | Sale | 7,132 | 29.84 | 212,804 |
| 2024-02-16 | Shah Gaurav (CEO) | Sale | 20,272 | 29.84 | 604,875 |
| 2024-02-16 | Wilson Martin (General Counsel) | Sale | 3,576 | 29.84 | 106,700 |
| 2024-02-16 | Militello John (See Remarks) | Sale | 3,238 | 29.84 | 96,615 |
| 2024-02-14 | Patel Kinnari (See Remarks) | Option Ex | 26,189 | .00 | 0 |
| 2024-02-14 | Shah Gaurav (CEO) | Option Ex | 46,828 | .00 | 0 |
| 2024-02-14 | Wilson Martin (General Counsel) | Option Ex | 9,712 | .00 | 0 |
| 2024-02-14 | Militello John (See Remarks) | Option Ex | 6,274 | .00 | 0 |
| 2024-01-22 | Militello John (See Remarks) | Sale | 638 | 27.20 | 17,355 |
| 2024-01-18 | Militello John (See Remarks) | Option Ex | 1,586 | .00 | 0 |
| 2023-11-15 | Makker Gotham | Sale | 20,000 | 22.53 | 450,640 |
| 2023-11-14 | Patel Kinnari (See Remarks) | Option Ex | 3,989 | .00 | 0 |
| 2023-11-14 | Shah Gaurav (CEO) | Option Ex | 7,979 | .00 | 0 |
| 2023-11-14 | Militello John (See Remarks) | Option Ex | 725 | .00 | 0 |
| 2023-10-20 | Militello John (See Remarks) | Sale | 564 | 17.06 | 9,622 |
| 2023-10-05 | Patel Kinnari (See Remarks) | Option Ex | 3,333 | .00 | 0 |
| 2023-09-29 | Makker Gotham | Sale | 4,677 | 21.14 | 98,862 |
| 2023-09-28 | Makker Gotham | Sale | 10,312 | 21.03 | 216,881 |
| 2023-08-17 | Patel Kinnari (See Remarks) | Sale | 1,534 | 15.47 | 23,732 |
| 2023-08-17 | Shah Gaurav (CEO) | Sale | 4,767 | 15.47 | 73,750 |
| 2023-08-17 | Militello John (See Remarks) | Sale | 284 | 15.47 | 4,393 |
| 2023-08-14 | Patel Kinnari (See Remarks) | Option Ex | 3,989 | .00 | 0 |
| 2023-08-14 | Shah Gaurav (CEO) | Option Ex | 7,979 | .00 | 0 |
| 2023-08-14 | Militello John (See Remarks) | Option Ex | 725 | .00 | 0 |
| 2023-07-20 | Militello John (See Remarks) | Sale | 573 | 19.03 | 10,905 |
| 2023-07-18 | Militello John (See Remarks) | Option Ex | 1,586 | .00 | 0 |
| 2023-05-17 | Patel Kinnari (See Remarks) | Sale | 1,330 | 21.38 | 28,428 |
| 2023-05-17 | Shah Gaurav (CEO) | Sale | 4,122 | 21.38 | 88,107 |
| 2023-05-17 | Militello John (See Remarks) | Sale | 245 | 21.38 | 5,236 |
| 2023-05-14 | Patel Kinnari (See Remarks) | Option Ex | 3,989 | .00 | 0 |
| 2023-05-14 | Shah Gaurav (CEO) | Option Ex | 7,979 | .00 | 0 |
| 2023-05-14 | Militello John (See Remarks) | Option Ex | 725 | .00 | 0 |
| 2023-04-21 | Militello John (See Remarks) | Sale | 2,342 | 18.65 | 43,678 |
| 2023-04-18 | Militello John (See Remarks) | Option Ex | 6,364 | .00 | 0 |
| 2023-02-17 | Schwartz Jonathan David (See Remarks) | Sale | 3,557 | 19.06 | 67,796 |
| 2023-02-17 | Shah Gaurav (CEO) | Sale | 12,194 | 19.06 | 232,417 |
| 2023-02-17 | Militello John (See Remarks) | Sale | 1,244 | 19.06 | 23,710 |
| 2022-10-06 | Wong Roderick | Buy | 1,355,932 | 14.75 | 19,999,997 |
| 2022-03-30 | Schwartz Jonathan David (See Remarks) | Sale | 45,000 | 16.25 | 731,250 |
| 2022-02-07 | Shah Gaurav (CEO) | Buy | 22,000 | 17.34 | 381,524 |
| 2021-06-17 | Makker Gotham | Sale | 400 | 47.12 | 18,850 |
| 2021-06-16 | Makker Gotham | Sale | 34,685 | 46.85 | 1,624,853 |
| 2021-05-11 | Yalamanchi Naveen | Sale | 725,000 | 40.03 | 29,023,199 |
| 2021-03-31 | Shah Gaurav (CEO) | Option Ex | 75,880 | 1.69 | 128,237 |
| 2021-03-24 | Patel Kinnari (Chief Operating Officer) | Option Ex | 93,962 | 1.45 | 136,244 |
| 2021-02-01 | Schwartz Jonathan David (Chief Medical Officer) | Option Ex | 224,529 | 1.45 | 325,567 |
| 2020-12-28 | Patel Kinnari (Chief Operating Officer) | Sale | 16,761 | 56.84 | 952,678 |
| 2020-12-10 | Yalamanchi Naveen | Buy | 247,720 | 56.00 | 13,872,320 |
| 2020-03-24 | Shah Gaurav (President & CEO) | Option Ex | 90,925 | .43 | 39,097 |
| 2020-03-18 | Patel Kinnari (Chief Operating Officer) | Buy | 1,000 | 9.50 | 9,500 |
| 2020-02-25 | Shah Gaurav (President & CEO) | Option Ex | 290,000 | .43 | 125,570 |
| 2019-12-10 | Yalamanchi Naveen | Buy | 225,000 | 22.25 | 5,006,250 |
| 2019-04-16 | Yalamanchi Naveen | Buy | 550,005 | 17.50 | 9,625,087 |
| 2019-03-05 | Shah Gaurav (See Remarks) | Sale | 25,000 | 16.90 | 422,499 |
| 2019-03-04 | Shah Gaurav (See Remarks) | Sale | 24,900 | 17.28 | 430,272 |
| 2019-03-01 | Shah Gaurav (See Remarks) | Sale | 25,000 | 17.34 | 433,500 |
| 2018-12-20 | Patel Kinnari (Chief Operating Officer) | Option Ex | 55,869 | 1.21 | 67,601 |
| 2018-12-13 | Southwell David P | Sale | 38,768 | 15.19 | 588,885 |
| 2018-12-07 | Southwell David P | Sale | 4,923 | 14.91 | 73,401 |
| 2018-12-06 | Patel Kinnari (Chief Operating Officer) | Buy | 5,675 | 14.98 | 85,011 |
| 2018-12-06 | Southwell David P | Sale | 52,809 | 15.15 | 800,056 |
| 2018-11-28 | Southwell David P | Option Ex | 153,125 | .00 | 0 |
| 2018-08-01 | Yalamanchi Naveen | Sale | 637 | 22.00 | 14,014 |
| 2018-04-02 | Southwell David P (Director) | Option Ex | 21,875 | .00 | 0 |
| 2017-09-14 | Ritter Dale (Vice President, Finance) | Option Ex | 12,500 | .00 | 0 |
| 2017-01-06 | Southwell David P (President and CEO) | Buy | 60,000 | 1.75 | 105,000 |
| 2016-05-13 | Carroll J Martin (Director) | Buy | 10,000 | 9.03 | 90,290 |
| 2015-07-14 | Kantesaria Devang (10% Owner) | Option Ex | 9,857 | 4.34 | 42,799 |
| 2015-02-23 | Pitango G.c. Capital Holdings Ltd. (10% Owner) | Buy | 212,375 | 6.00 | 1,274,250 |
| 2015-02-23 | Kantesaria Devang (10% Owner) | Buy | 814,166 | 6.00 | 4,884,996 |
| 2015-02-23 | Devon Park Associates, Llc (10% Owner) | Buy | 814,166 | 6.00 | 4,884,996 |
| 2015-02-23 | Care Capital Offshore Investments Iii Lp (10% Owner) | Buy | 603,832 | 6.00 | 3,622,992 |
| 2015-02-23 | Medimmune Ventures, Inc. (10% Owner) | Buy | 416,667 | 6.00 | 2,500,002 |
| 2015-02-23 | Karabelas Argeris N (Director) | Buy | 603,832 | 6.00 | 3,622,992 |
| 2015-02-23 | Leschly Mark (10% Owner) | Buy | 958,226 | 6.00 | 5,749,356 |
Insider trading activities including stock purchases, stock sales, and option exercises of RCKT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rocket Pharmaceuticals, Inc. (symbol RCKT, CIK number 1281895) see the Securities and Exchange Commission (SEC) website.